Айдифа(энасидениб)50 mgthirtyТабLucius, Бангладеш Enasidenib is an isocitrate dehydrogenase-2 inhibitor that inhibits several enzymes responsible for tumor growth. \r\n Indications \r\n For the treatment of adult patients with relapsed or refractory myeloid leukemia who have a specific mutation in the IDH2 gene.
